Loading [MathJax]/extensions/tex2jax.js

Thrombogenicity Assessment of Perfusable Tissue-Engineered Constructs: A Systematic Review

Research output: Contribution to journalReview articleResearchpeer review

Authors

  • Luna Haderer
  • Yijun Zhou
  • Peter Tang
  • Assal Daneshgar
  • Marie Weinhart

External Research Organisations

  • Berlin Institute of Health (BIH)
  • Freie Universität Berlin (FU Berlin)
  • German Research Foundation (DFG)

Details

Original languageEnglish
Pages (from-to)126 - 161
Number of pages36
JournalTissue Engineering - Part B: Reviews
Volume31
Issue number2
Early online date5 Feb 2025
Publication statusPublished - 14 Apr 2025

Abstract

Vascular surgery is facing a critical demand for novel vascular grafts that are biocompatible and thromboresistant. This urgency is particularly applicable to bypass operations involving small caliber vessels. In the realm of tissue engineering, the development of fully vascularized organs is promising as a solution to organ shortage for transplantation. To achieve this, it is essential to (re)construct a biocompatible and nonthrombogenic vascular network within these organs. In this systematic review, we identify, classify, and discuss basic principles and methods used to perform in vitro/ex vivo dynamic thrombogenicity testing of perfusable tissue-engineered organs and tissues. We conducted a preregistered systematic review of studies published in the last 23 years according to PRISMA-P Guidelines. This comprised a systematic data extraction, in-depth analysis, and risk of bias assessment of 116 included studies. We identified shaking (n = 28), flow loop (n = 17), ex vivo (arteriovenous shunt, n = 33), and dynamic in vitro models (n = 38) as the main approaches for thrombogenicity assessment. This comprehensive review reveals a prevalent lack of standardization and provides a valuable guide in the design of standardized experimental setups.

Keywords

    perfusion, thrombogenicity, tissue engineering, whole blood

ASJC Scopus subject areas

Cite this

Thrombogenicity Assessment of Perfusable Tissue-Engineered Constructs: A Systematic Review. / Haderer, Luna; Zhou, Yijun; Tang, Peter et al.
In: Tissue Engineering - Part B: Reviews, Vol. 31, No. 2, 14.04.2025, p. 126 - 161.

Research output: Contribution to journalReview articleResearchpeer review

Haderer, L, Zhou, Y, Tang, P, Daneshgar, A, Globke, B, Krenzien, F, Reutzel-Selke, A, Weinhart, M, Pratschke, J, Sauer, IM, Hillebrandt, KH & Keshi, E 2025, 'Thrombogenicity Assessment of Perfusable Tissue-Engineered Constructs: A Systematic Review', Tissue Engineering - Part B: Reviews, vol. 31, no. 2, pp. 126 - 161. https://doi.org/10.1089/ten.teb.2024.0078
Haderer, L., Zhou, Y., Tang, P., Daneshgar, A., Globke, B., Krenzien, F., Reutzel-Selke, A., Weinhart, M., Pratschke, J., Sauer, I. M., Hillebrandt, K. H., & Keshi, E. (2025). Thrombogenicity Assessment of Perfusable Tissue-Engineered Constructs: A Systematic Review. Tissue Engineering - Part B: Reviews, 31(2), 126 - 161. https://doi.org/10.1089/ten.teb.2024.0078
Haderer L, Zhou Y, Tang P, Daneshgar A, Globke B, Krenzien F et al. Thrombogenicity Assessment of Perfusable Tissue-Engineered Constructs: A Systematic Review. Tissue Engineering - Part B: Reviews. 2025 Apr 14;31(2):126 - 161. Epub 2025 Feb 5. doi: 10.1089/ten.teb.2024.0078
Haderer, Luna ; Zhou, Yijun ; Tang, Peter et al. / Thrombogenicity Assessment of Perfusable Tissue-Engineered Constructs : A Systematic Review. In: Tissue Engineering - Part B: Reviews. 2025 ; Vol. 31, No. 2. pp. 126 - 161.
Download
@article{00f85fc4561e4c8886e2a546d3f198fc,
title = "Thrombogenicity Assessment of Perfusable Tissue-Engineered Constructs: A Systematic Review",
abstract = "Vascular surgery is facing a critical demand for novel vascular grafts that are biocompatible and thromboresistant. This urgency is particularly applicable to bypass operations involving small caliber vessels. In the realm of tissue engineering, the development of fully vascularized organs is promising as a solution to organ shortage for transplantation. To achieve this, it is essential to (re)construct a biocompatible and nonthrombogenic vascular network within these organs. In this systematic review, we identify, classify, and discuss basic principles and methods used to perform in vitro/ex vivo dynamic thrombogenicity testing of perfusable tissue-engineered organs and tissues. We conducted a preregistered systematic review of studies published in the last 23 years according to PRISMA-P Guidelines. This comprised a systematic data extraction, in-depth analysis, and risk of bias assessment of 116 included studies. We identified shaking (n = 28), flow loop (n = 17), ex vivo (arteriovenous shunt, n = 33), and dynamic in vitro models (n = 38) as the main approaches for thrombogenicity assessment. This comprehensive review reveals a prevalent lack of standardization and provides a valuable guide in the design of standardized experimental setups.",
keywords = "perfusion, thrombogenicity, tissue engineering, whole blood",
author = "Luna Haderer and Yijun Zhou and Peter Tang and Assal Daneshgar and Brigitta Globke and Felix Krenzien and Anja Reutzel-Selke and Marie Weinhart and Johann Pratschke and Sauer, {Igor Maximillian} and Hillebrandt, {Karl Herbert} and Eriselda Keshi",
note = "Publisher Copyright: Copyright 2025, Mary Ann Liebert, Inc., publishers.",
year = "2025",
month = apr,
day = "14",
doi = "10.1089/ten.teb.2024.0078",
language = "English",
volume = "31",
pages = "126 -- 161",
number = "2",

}

Download

TY - JOUR

T1 - Thrombogenicity Assessment of Perfusable Tissue-Engineered Constructs

T2 - A Systematic Review

AU - Haderer, Luna

AU - Zhou, Yijun

AU - Tang, Peter

AU - Daneshgar, Assal

AU - Globke, Brigitta

AU - Krenzien, Felix

AU - Reutzel-Selke, Anja

AU - Weinhart, Marie

AU - Pratschke, Johann

AU - Sauer, Igor Maximillian

AU - Hillebrandt, Karl Herbert

AU - Keshi, Eriselda

N1 - Publisher Copyright: Copyright 2025, Mary Ann Liebert, Inc., publishers.

PY - 2025/4/14

Y1 - 2025/4/14

N2 - Vascular surgery is facing a critical demand for novel vascular grafts that are biocompatible and thromboresistant. This urgency is particularly applicable to bypass operations involving small caliber vessels. In the realm of tissue engineering, the development of fully vascularized organs is promising as a solution to organ shortage for transplantation. To achieve this, it is essential to (re)construct a biocompatible and nonthrombogenic vascular network within these organs. In this systematic review, we identify, classify, and discuss basic principles and methods used to perform in vitro/ex vivo dynamic thrombogenicity testing of perfusable tissue-engineered organs and tissues. We conducted a preregistered systematic review of studies published in the last 23 years according to PRISMA-P Guidelines. This comprised a systematic data extraction, in-depth analysis, and risk of bias assessment of 116 included studies. We identified shaking (n = 28), flow loop (n = 17), ex vivo (arteriovenous shunt, n = 33), and dynamic in vitro models (n = 38) as the main approaches for thrombogenicity assessment. This comprehensive review reveals a prevalent lack of standardization and provides a valuable guide in the design of standardized experimental setups.

AB - Vascular surgery is facing a critical demand for novel vascular grafts that are biocompatible and thromboresistant. This urgency is particularly applicable to bypass operations involving small caliber vessels. In the realm of tissue engineering, the development of fully vascularized organs is promising as a solution to organ shortage for transplantation. To achieve this, it is essential to (re)construct a biocompatible and nonthrombogenic vascular network within these organs. In this systematic review, we identify, classify, and discuss basic principles and methods used to perform in vitro/ex vivo dynamic thrombogenicity testing of perfusable tissue-engineered organs and tissues. We conducted a preregistered systematic review of studies published in the last 23 years according to PRISMA-P Guidelines. This comprised a systematic data extraction, in-depth analysis, and risk of bias assessment of 116 included studies. We identified shaking (n = 28), flow loop (n = 17), ex vivo (arteriovenous shunt, n = 33), and dynamic in vitro models (n = 38) as the main approaches for thrombogenicity assessment. This comprehensive review reveals a prevalent lack of standardization and provides a valuable guide in the design of standardized experimental setups.

KW - perfusion

KW - thrombogenicity

KW - tissue engineering

KW - whole blood

UR - http://www.scopus.com/inward/record.url?scp=85217020203&partnerID=8YFLogxK

U2 - 10.1089/ten.teb.2024.0078

DO - 10.1089/ten.teb.2024.0078

M3 - Review article

C2 - 39007511

AN - SCOPUS:85217020203

VL - 31

SP - 126

EP - 161

JO - Tissue Engineering - Part B: Reviews

JF - Tissue Engineering - Part B: Reviews

SN - 1937-3368

IS - 2

ER -

By the same author(s)